Ent638_0521 is annotated as a UPF0442 family protein, a classification typically assigned to hypothetical proteins of unknown function. The recombinant form is produced in Escherichia coli expression systems, tagged with hexahistidine (His) for purification, and corresponds to the full-length protein (residues 1–157) of the Ent638_0521 gene . Its UniProt identifier is A4W678, and it is associated with Enterobacter sp. strain 638, a Gram-negative bacterium within the Enterobacteriaceae family .
Commercial production involves recombinant expression in E. coli, followed by affinity chromatography using His-tag purification. Specifications include:
| Parameter | Details |
|---|---|
| Expression system | E. coli |
| Tag | N-terminal His-tag |
| Purity | >90% (SDS-PAGE verified) |
| Form | Lyophilized powder in Tris/PBS buffer with 6% trehalose |
| Storage | -20°C/-80°C; avoid repeated freeze-thaw cycles |
| Reconstitution | Deionized water or compatible buffers; glycerol (5–50%) for long-term storage |
While functional studies of Ent638_0521 are not publicly documented, its commercial availability suggests potential uses in:
Antibody development: As an immunogen for polyclonal or monoclonal antibody production.
Structural studies: For crystallization or NMR analysis due to its small size and solubility.
Pathogenicity research: Enterobacter spp. are opportunistic pathogens, and hypothetical proteins like Ent638_0521 may contribute to virulence mechanisms .
Functional annotation: No experimental data on enzymatic activity, substrate binding, or interaction partners are available .
Pathway involvement: Public databases (e.g., KEGG, STRING) lack annotated pathways for Ent638_0521 .
Clinical relevance: Enterobacter sp. 638 is not directly linked to human disease, though related species exhibit antibiotic resistance and nosocomial infection potential .
KEGG: ent:Ent638_0521
STRING: 399742.Ent638_0521
Ent638_0521 is a hypothetical protein of unknown function belonging to the UPF0442 protein family. It originates from Enterobacter sp. strain 638, a Gram-negative bacterium within the Enterobacteriaceae family. The recombinant form corresponds to the full-length protein (residues 1-157) of the Ent638_0521 gene and has a UniProt identifier of A4W678. The protein is typically produced using Escherichia coli expression systems and is tagged with hexahistidine (His) for purification purposes.
The UPF0442 classification indicates that this is a protein of unknown function that shares sequence homology with other proteins in this family. Despite its uncharacterized nature, its conservation across bacterial species suggests potential biological significance that warrants investigation.
Bioinformatic analyses suggest that Ent638_0521 shares sequence similarity with other UPF0442 family proteins across diverse bacterial species. Comparative genomic approaches indicate that homologs are present in multiple Enterobacter species with high sequence conservation. For instance, Enterobacter sp. AS-1, which has been characterized as a potential recombinant host, likely contains homologous proteins as suggested by its genomic profile with 4,921 predicted coding sequences .
Phylogenetic analyses based on 16S rRNA gene sequences have positioned various Enterobacter species in relation to one another. Enterobacter sp. AS-1, for example, exhibits similarities of 99.8% to E. sichuanensis WCHECL1597, 99.7% to E. chengduensis WCHECl-C4, 99.5% to E. wuhouensis WCHEs120002, and 99.3% to E. chuandaensis 90028 . These relationships provide context for understanding the evolutionary conservation of proteins like Ent638_0521 across the genus.
The optimal expression system for Ent638_0521 production depends on research objectives, but E. coli remains the most widely used host for this protein. When selecting an expression system, researchers should consider several factors:
E. coli-based expression:
BL21(DE3) strains are commonly used due to their reduced protease activity and compatibility with T7 promoter systems
Rosetta or Origami strains may improve expression if rare codons or disulfide bonds are present
The BL21-derived C41 and C43 strains show higher recombinant protein production with reduced acetate production, which can improve yield
Alternative expression systems to consider:
Eurytrophic hosts like Enterobacter sp. AS-1 show promise as recombinant hosts, particularly when minimal media or variable nutritional conditions are desired
For structural or functional studies requiring post-translational modifications, eukaryotic systems may be preferred, though no specific reports of Ent638_0521 expression in these systems exist
Promoter selection significantly impacts recombinant protein expression levels, inducibility, and metabolic burden. For Ent638_0521 expression, several promoter systems can be considered:
| Promoter | Characteristics | Advantages | Limitations |
|---|---|---|---|
| T7 | Strong, highly inducible with IPTG | High expression levels; tight regulation | Metabolic burden; potential toxicity; leaky expression in some systems |
| trc | Moderate strength, IPTG-inducible | Balanced expression; reduced metabolic burden | Lower yield than T7; some basal expression |
| tac | Similar to trc but slightly stronger | Good balance of yield and regulation | Moderate basal expression |
| BAD | Arabinose-inducible | Fine-tunable expression; very tight regulation | Lower maximum yield; catabolite repression issues |
Research has shown that metabolic burden associated with transcription and translation of foreign genes can decrease recombinant protein expression. The choice between high-copy-number plasmids (pMB1) and low-copy-number plasmids (p15A) also impacts expression levels and cellular stress .
The standard purification strategy for recombinant His-tagged Ent638_0521 involves immobilized metal affinity chromatography (IMAC), but additional steps can enhance purity:
Primary purification (IMAC):
Equilibrate Ni-NTA or similar resin with binding buffer (typically 20-50 mM Tris-HCl pH 8.0, 300-500 mM NaCl, 10-20 mM imidazole)
Apply clarified cell lysate to the column
Wash with binding buffer containing incrementally higher imidazole concentrations (20-50 mM) to remove non-specifically bound proteins
Elute with elution buffer containing 250-500 mM imidazole
Secondary purification options:
Size exclusion chromatography (SEC) for removing aggregates and achieving higher purity
Ion exchange chromatography (IEX) as an orthogonal purification step
Hydrophobic interaction chromatography (HIC) for removing contaminants with different hydrophobicity profiles
Purification assessment:
SDS-PAGE analysis with Coomassie staining (target: >90% purity)
Western blotting using anti-His antibodies for specific detection
Mass spectrometry for identity confirmation
For long-term storage, the addition of 5-50% glycerol to purified protein samples is recommended to prevent freeze-thaw damage. Additionally, lyophilization in the presence of stabilizers like trehalose (6%) can maintain protein integrity during extended storage periods.
Determining the function of an uncharacterized protein like Ent638_0521 requires a multi-faceted approach:
Computational prediction approaches:
Sequence homology analysis against characterized proteins
Structural homology modeling and comparison with known protein structures
Genomic context analysis (neighboring genes often have related functions)
Protein domain and motif identification
Experimental approaches:
Protein-protein interaction studies:
Pull-down assays using His-tagged Ent638_0521 as bait
Bacterial two-hybrid or yeast two-hybrid screening
Co-immunoprecipitation followed by mass spectrometry
Gene knockout/complementation studies:
CRISPR-Cas9 or traditional homologous recombination methods to create knockout strains
Phenotypic analysis under various stress conditions
Complementation with wild-type gene to confirm phenotype
Biochemical assays:
General enzymatic activity screening (hydrolase, kinase, binding assays)
Substrate screening using metabolite arrays or biochemical libraries
Structural studies (X-ray crystallography, NMR) that might reveal potential active sites
Transcriptomic/proteomic profiling:
RNA-seq to identify co-regulated genes
Proteomics to identify changes in protein abundance in response to Ent638_0521 deletion
Based on the taxonomic context, investigation into potential roles in bacterial pathogenicity, stress response, or metabolic pathways could be particularly relevant, as Enterobacter species are known opportunistic pathogens with complex virulence mechanisms .
Investigating protein-protein interactions for Ent638_0521 requires a systematic approach:
Affinity purification-mass spectrometry (AP-MS):
Express His-tagged or tandem affinity purification (TAP)-tagged Ent638_0521 in Enterobacter sp. or E. coli
Perform mild lysis to preserve protein complexes
Capture protein complexes via affinity chromatography
Identify binding partners using LC-MS/MS
Confirm interactions using reciprocal pull-downs or co-immunoprecipitation
Crosslinking-MS approaches:
Treat cells expressing Ent638_0521 with protein crosslinkers (e.g., formaldehyde, DSS)
Purify Ent638_0521 under denaturing conditions
Identify crosslinked peptides by MS/MS to map interaction interfaces
Bacterial two-hybrid system:
Clone Ent638_0521 into a bacterial two-hybrid bait vector
Screen against a prey library constructed from Enterobacter genomic DNA
Validate positive interactions through secondary screens
Co-expression studies:
Identify genes co-regulated with Ent638_0521 through transcriptomic analysis
Investigate co-occurrence patterns across bacterial genomes
Test for physical interactions between co-expressed proteins
Since Enterobacter species contain Type VI secretion systems (T6SS) as identified in Enterobacter sp. S-33 , investigating potential interactions between Ent638_0521 and T6SS components could be particularly informative if the protein functions in bacterial virulence or competitive fitness.
Several structural analysis techniques are suitable for characterizing Ent638_0521, with the choice depending on research objectives:
X-ray crystallography:
Advantages: High-resolution structure determination (potentially atomic resolution)
Approach: Screen crystallization conditions using commercial sparse matrix screens; optimize promising conditions; collect diffraction data; solve structure through molecular replacement or experimental phasing
Considerations: Requires relatively large amounts of pure, homogeneous protein; crystallization may be challenging
Nuclear Magnetic Resonance (NMR) spectroscopy:
Advantages: Structure determination in solution; dynamics information; interaction mapping
Approach: Express isotopically labeled protein (13C, 15N); collect multi-dimensional NMR spectra; assign resonances; calculate structure
Considerations: Size limitation (favorable for Ent638_0521 at 157 residues); requires high protein concentration and stability
Cryo-electron microscopy (cryo-EM):
Advantages: No crystallization required; visualization of protein complexes
Approach: Usually applied to larger complexes; may be suitable if Ent638_0521 forms larger assemblies
Considerations: Traditional single-particle cryo-EM has lower resolution for small proteins, though advances in microED are changing this
Small-angle X-ray scattering (SAXS):
Advantages: Low-resolution envelope in solution; information on oligomeric state
Approach: Collect scattering data at multiple concentrations; generate ab initio models
Considerations: Limited resolution; complementary to other methods
Circular dichroism (CD) spectroscopy:
Advantages: Rapid assessment of secondary structure content; thermal stability
Approach: Measure far-UV CD spectra; perform thermal denaturation
Considerations: Limited to secondary structure estimation; no atomic-level details
The small size of Ent638_0521 (157 amino acids) makes it particularly amenable to NMR structure determination, while its potential for crystallization also makes X-ray crystallography a viable option. A hierarchical approach beginning with CD spectroscopy for initial characterization, followed by more detailed structural analysis using either NMR or X-ray crystallography, would be most efficient.
While the specific role of Ent638_0521 in pathogenicity is not established, its study could contribute to understanding Enterobacter virulence mechanisms through several approaches:
Comparative genomics approach:
Compare the presence and sequence conservation of Ent638_0521 across pathogenic and non-pathogenic Enterobacter strains
Analyze genomic context for proximity to known virulence factors
Examine the protein's relationship to type VI secretion system (T6SS) components, as T6SS has been identified in Enterobacter species like S-33
Phenotypic characterization:
Generate knockout mutants lacking the Ent638_0521 gene
Assess changes in:
Host interaction studies:
Investigate Ent638_0521 mutant behavior in:
Adhesion to epithelial cell lines
Invasion assays
Persistence in macrophage models
Animal infection models (if appropriate)
Secretion and localization analysis:
Determine subcellular localization using fractionation and immunoblotting
Assess if Ent638_0521 is secreted under specific conditions
Evaluate potential interaction with host factors using pull-down assays
Recent genomic characterization of Enterobacter sp. S-33 revealed various virulence factors, including drug-efflux genes (acrA, acrB) and outer membrane proteins (OmpA, OmpC, OmpF) . Investigating whether Ent638_0521 interacts with these components could provide insights into its potential role in antibiotic resistance or membrane integrity.
Several gene editing approaches can be employed for functional studies of Ent638_0521 in Enterobacter sp.:
CRISPR-Cas9 system:
Design sgRNAs targeting Ent638_0521 with minimal off-target effects
Clone sgRNA into a CRISPR-Cas9 vector compatible with Enterobacter
Introduce a homology-directed repair template for gene deletion or modification
Screen transformants for successful editing
Verify edits by sequencing and phenotypic analysis
Traditional homologous recombination:
Create a knockout cassette with antibiotic resistance marker flanked by homology arms
Transform into Enterobacter using electroporation protocols optimized for species like AS-1
Select on appropriate antibiotics and screen for successful recombination
Confirm gene deletion using PCR and sequencing
Transposon mutagenesis:
Use Tn5 or similar transposon systems for random mutagenesis
Screen for colonies with transposon insertions in Ent638_0521
Characterize resulting mutants phenotypically
Plasmid-based approaches:
For complementation studies, clone wild-type Ent638_0521 into vectors like pUC19
For overexpression studies, use inducible promoters (T7, trc, tac, or BAD)
For protein localization studies, create fusion proteins with fluorescent tags
For transformation of Enterobacter species, electroporation has proven effective. The protocol used with Enterobacter sp. AS-1 (Gene Pulser II, Bio-Rad) allowed successful introduction of pUC19 plasmid, with transformants verified by their ability to form colonies on R2A + ampicillin medium . This approach could be adapted for introducing gene editing constructs targeting Ent638_0521.
Investigating the role of Ent638_0521 in stress responses requires a systematic approach comparing wild-type and mutant strains under various conditions:
Stress challenge experiments:
Generate Ent638_0521 knockout and complemented strains
Subject strains to various stressors:
Oxidative stress (H₂O₂, paraquat)
Acid stress (pH range 3-6)
Osmotic stress (high salt, sucrose)
Nutrient limitation (minimal media, carbon source restriction)
Antimicrobial compounds
Monitor growth rates, survival, and morphological changes
Quantify stress-specific markers (e.g., ROS levels, membrane integrity)
Transcriptomic and proteomic profiling:
Compare expression profiles of wild-type and Ent638_0521 mutants under:
Normal growth conditions
Various stress conditions
Identify differentially expressed genes/proteins
Perform pathway enrichment analysis to identify affected cellular processes
Validate key findings with RT-qPCR or targeted proteomic approaches
Protein localization and dynamics:
Create fluorescent protein fusions to track Ent638_0521 localization
Monitor changes in localization upon stress exposure
Assess protein-protein interactions under stress conditions
Measure protein turnover rates in different environments
Phenotypic microarray:
Use Biolog or similar systems to simultaneously test growth under hundreds of conditions
Identify specific conditions where Ent638_0521 contributes to fitness
Perform validation experiments for promising phenotypes
Enterobacter sp. AS-1's ability to grow on both rich media and water agar (containing no organic matter except agar) demonstrates adaptation to nutritional stress . Studying whether Ent638_0521 contributes to this eurytrophic capability could reveal its role in nutrient stress adaptation. Similarly, the motility behavior observed in Enterobacter sp. S-33, which contributes to persistence in stressed environments , might be influenced by proteins like Ent638_0521.
Optimizing soluble expression of Ent638_0521 requires systematic adjustment of expression conditions:
Expression strain optimization:
Compare standard BL21(DE3) with specialized strains:
Rosetta strains for rare codon usage
Origami strains for disulfide bond formation
C41/C43 strains for potentially toxic proteins
Arctic Express for low-temperature expression
Consider Enterobacter sp. AS-1 as an alternative host, particularly if studying native function
Expression vector and promoter selection:
Test different promoter strengths (T7, trc, tac, BAD)
Compare high-copy (pMB1) vs. low-copy (p15A) plasmid backbones
Evaluate different fusion tags beyond His-tag (MBP, GST, SUMO) which can enhance solubility
Induction parameters optimization:
Test induction at different OD₆₀₀ values (0.5-1.0)
Try range of inducer concentrations:
IPTG: 0.1-1.0 mM
Arabinose: 0.002-0.2% for BAD promoter
Vary post-induction temperatures (18°C, 25°C, 30°C)
Test different expression durations (4h, 8h, overnight)
Media and growth conditions:
Compare rich media (LB, TB, 2xYT) with defined media
Test addition of solubility enhancers:
Sorbitol (0.5-1.0 M)
Glycine betaine (2.5 mM)
Low concentrations of ethanol (1-3%)
Consider auto-induction media for gradual protein expression
Co-expression strategies:
Co-express with molecular chaperones (GroEL/ES, DnaK/J)
Co-express with foldases if disulfide bonds are present
The metabolic burden associated with recombinant protein expression often leads to decreased yield. To address this, systematic optimization of the expression system is crucial. Studies have shown that BL21 derivative strains like C41 can show higher recombinant protein production due to reduced acetate production and excretion to the extracellular medium .
Multiple bioinformatic approaches can be employed to predict the function of uncharacterized proteins like Ent638_0521:
Sequence-based predictions:
Homology detection:
BLAST against non-redundant protein databases
Position-Specific Iterated BLAST (PSI-BLAST) for remote homologs
Profile Hidden Markov Models (HMMs) using HMMER
Conserved domain analysis:
InterPro, CDD, SMART for identifying protein domains
Pfam for protein family classification
Motif identification:
PROSITE patterns for functional motifs
ELM for linear motifs
Structure-based predictions:
Structural modeling:
AlphaFold2 or RoseTTAFold for ab initio structure prediction
I-TASSER or SWISS-MODEL for homology modeling
Structural comparison:
DALI or VAST+ for identifying structural homologs
ProFunc for structure-based function prediction
Binding site prediction:
3DLigandSite for ligand binding site prediction
COFACTOR for enzyme active site prediction
Genomic context analysis:
Gene neighborhood analysis:
Examine consistently co-located genes across multiple genomes
Identify operonic structures
Gene fusion detection:
Identify domain fusions that suggest functional relationships
Phylogenetic profiling:
Identify proteins with similar phylogenetic distributions
Systems biology approaches:
Co-expression analysis:
Examine publicly available transcriptomic data
Identify genes with similar expression patterns
Protein-protein interaction prediction:
STRING database for predicted and known interactions
InterPreTS for structurally predicted interactions
For Ent638_0521, detailed genomic context analysis would be particularly valuable given the availability of complete genome sequences for multiple Enterobacter species, including AS-1 and S-33 . Comparative analysis of genomic neighborhoods across these genomes could reveal conserved gene clusters that provide functional hints.
Common issues in recombinant protein expression and purification can be systematically addressed:
Low expression yield troubleshooting:
Verify plasmid sequence integrity
Check for rare codons and consider codon-optimized constructs
Test different media formulations and growth conditions
Evaluate promoter strength and induction parameters
Monitor protein expression over time to identify optimal harvest point
Consider metabolic burden effects - lower copy number vectors or weaker promoters might increase yield
Insoluble protein/inclusion body troubleshooting:
Reduce induction temperature (16-20°C)
Decrease inducer concentration
Use solubility-enhancing fusion tags (MBP, SUMO)
Co-express with molecular chaperones
Develop inclusion body refolding protocol:
Solubilize in 8M urea or 6M guanidine-HCl
Perform stepwise dialysis to remove denaturant
Add appropriate redox agents if disulfide bonds are present
Purification troubleshooting:
His-tag binding issues:
Verify tag is not cleaved (Western blot)
Adjust imidazole concentration in binding buffer
Check metal ion leaching (recharge column)
Ensure proper pH (typically 7.5-8.0)
Protein aggregation:
Add stabilizing agents (glycerol, arginine)
Include reducing agents if appropriate
Optimize buffer conditions (pH, salt concentration)
Protein degradation:
Add protease inhibitors
Perform purification at 4°C
Minimize time between lysis and purification
Consider adding EDTA (if compatible) to inhibit metalloproteases
Protein activity issues:
Verify proper folding:
Circular dichroism spectroscopy
Fluorescence spectroscopy
Limited proteolysis
Check for inhibitory compounds:
Dialyze extensively to remove imidazole
Test different storage buffers
Assess oligomeric state:
Size exclusion chromatography
Dynamic light scattering
For successful purification of recombinant Ent638_0521, maintaining the protein in Tris/PBS buffer with 6% trehalose as a stabilizer has been reported to be effective. Additionally, avoiding repeated freeze-thaw cycles and adding glycerol (5–50%) for long-term storage can help preserve protein integrity.